ARTICLE | Clinical News
Perjeta pertuzumab regulatory update
August 10, 2015 7:00 AM UTC
Roche said that the European Commission approved an expanded label for Perjeta pertuzumab to include its use in combination with Herceptin trastuzumab and chemotherapy for the neoadjuvant treatment o...